IPO activity looks likely to stay in an uptrend into mid-year – especially in the U.S. Of course, a lot can change over the course of a year, so we’ll be updating our Nasdaq IPO Pulses each ...

"I can say for Nasdaq, we're very proud of what we do ... Friedman is ultimately bullish on IPO outlooks as the Trump administration loosens up regulations.

TOKYO and NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Spirit Advisors LLC proudly announces the successful completion of the initial public offering (IPO) of PicoCELA Inc. (Nasdaq: PCLA), a pioneer in ...

Jay Heller, VP, Head of Capital Markets, Nasdaq In 2024, we proudly welcomed leading IPOs including Lineage, Kaspi.kz, Waystar, BrightSpring Health Services, and Onestream. You're in great company ...

And based on our IPO Pulses, IPO activity looks likely to stay in an uptrend into mid-year – especially in the U.S. Of course, a lot can change over the course of a year, so we’ll be updating our ...

Shares of GE HealthCare (GEHC) jumped 9% Thursday after the company issued its Q4 earnings report and 2025 forecast. Read more here.

Dr Agarwal’s Health Care IPO date: The book build issue is opening on 29 January 2025 and will remain open until 31 January 2025.(Photo: Courtesy company website) Here we list out important Dr ...

Maze Therapeutics ( NASDAQ: MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...

The California-based company is set to begin trading on the Nasdaq, with 7.5 million shares priced between $14 and $16 apiece under the ticker BBNX—an IPO range that would give Beta Bionics ...

Change Healthcare, the UnitedHealth-owned health tech company that lost more than 100 million people’s sensitive health data in a ransomware attack last year, said on Tuesday that the company ...

A subscription component is also available for eligible employees. Should you apply for Dr. Agarwal's Health Care IPO? Here's what market expert Anil Singhvi has to say Zee Business Managing Editor ...

The company has around 25% of its market share in its eye care-related services business. We believe the issue is richly priced and recommend a "Subscribe – Long Term" rating for the IPO." ...